Open ICICI 3-in-1 Account

ASTRAZENECA PHARMA INDIA SHARE PRICE

Sector Pharmaceuticals
BSE 506820
NSE ASTRAZEN
7,954.50
-82.00 (-1.02 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

7,933.00

Day High

8,093.00

52 Week Low

5,468.05

52 Week High

9,211.00

All Time Low

170.00

All Time High

9,211.00

Open

8,002.50

Close

8,036.50

Volume

11,500

Mkt cap (Cr)

19,886.25

P/E ratio

119.91

P/B ratio

0.03%

Div yield

0.30%

6M return

17.45%

1Y return

45.76%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

7,954.50 -1.02%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Astrazeneca Pharma India Ltd

Stock PE (TTM)

118.53

Promoter Holding

75%

Book Value

271.74

ROCE

33.26%

ROE

24.84%

AstraZeneca Pharmaceuticals Ltd is in the Pharmaceuticals sector is having a market capitalization worth Rs. 7,640.88 crores, it is incorporated in the year 1979. It has reported standalone sales of Rs. 175.40 crores in June 2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 506820, and also listed on the National Stock Exchange (NSE) with the code ASTRAZEN.

AstraZeneca Pharma deals in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology, and respiratory. It has a workforce of 1400 people across the country. Its manufacturing facility is certified with ISO 14001. AstraZeneca has established a Research & Development facility in Bangalore equipped with a team of 90 employees consisting of scientific experts in the field of regulatory science, clinical science, and patient safety. Its production unit is located in the city of Bengaluru. The company’s plant was the first pharma facility in India to be accredited with Gold Standard Rating under LEED (Leadership in Energy and Environmental Design) certification. The promoters own 75.0% of the stake in the company, Foreign Institutional Investors (FII) own 2.42% of the stake, Domestic Institutional Investors (DII) own 1.02%, and others (such as public & retail investors) hold the balance of 21.56%.

In June 2021, quarterly net revenue was Rs. 175.4 crores, which has decreased by approximately 9.39 % from Rs. 193.58 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 10.24 crores, which has improved sharply and decreased by nearly 45.03% from a net profit of Rs. 18.63 crores in June 2020. In June 2021, the reported operating profit was at Rs. 141.09 crores, which is decreased by 11.79% as compared to an operating profit of Rs. 159.95 crores for the quarter ending in June 2020. From an EPS of Rs. 18.63 in June 2020, the EPS of AstraZeneca Pharmaceuticals Ltd has reduced and reached an EPS of Rs. 10.24 per share in June 2021. ASTRAZEN's stock closed at Rs. 3,056.35 on 27th August’2021 (NSE). AstraZeneca Pharmaceuticals Ltd has returned 11.06% negatively in the last six months and returned 13.50% negatively in the previous year.

Astrazeneca Pharma India share price as on 16 May 2025 is Rs. 7954.5. Over the past 6 months, the Astrazeneca Pharma India share price has increased by 17.45% and in the last one year, it has increased by 45.76%. The 52-week low for Astrazeneca Pharma India share price was Rs. 5468.05 and 52-week high was Rs. 9211.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

506820

ASTRAZEN

INE203A01020

Aug

Astrazeneca Pharma India Ltd FAQs

You can buy Astrazeneca Pharma India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Astrazeneca Pharma India Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 15, 2025 03:59 PM the closing price of Astrazeneca Pharma India Ltd was Rs.7,954.50.

The latest PE ratio of Astrazeneca Pharma India Ltd as of May 15, 2025 03:59 PM is 118.53

The latest PB ratio of Astrazeneca Pharma India Ltd as of May 15, 2025 03:59 PM is 0.03

The 52-week high of Astrazeneca Pharma India Ltd share price is Rs. 9,211.00 while the 52-week low is Rs. 5,468.05

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 15, 2025 03:59 PM, the market cap of Astrazeneca Pharma India Ltd stood at Rs. 19,886.25 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.